Trusted ways to increase lung cancer screening
Official title: Developing a Trustworthy Multilevel Intervention to Improve Lung Cancer Screening
Funded at Wake Forest University Health Sciences · NIH-11143706 · Data updated 2026-11-12
This project will try patient- and clinic-level strategies to help people eligible for low-dose CT get lung cancer screening.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $249,000 |
| NIH project number | 5R00CA277366-04 |
| Project ID | NIH-11143706 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are people who meet current guidelines for low-dose CT lung cancer screening, especially those from communities with low screening rates.
✕Less likely to help
People who do not meet screening guidelines, are already up-to-date with screening, or are unable or unwilling to take part in clinic-based interventions may not benefit.
What this research studies
You would be part of work that starts by talking with people in affected communities, nurses, and doctors to learn what gets in the way of lung cancer screening. The team will work with community advisors and health system stakeholders to co-design trustworthy strategies aimed at patients and at providers or clinics. They will then pilot one patient-facing and one provider/system-facing strategy in real clinics to see if the approaches are practical and acceptable. The study focuses on people eligible for low-dose CT and on clinic teams to make the solutions useful where you get care.
Why it matters
Potential benefit: If successful, the work could help more eligible people get low-dose CT scans so lung cancers are found earlier and lives are saved.
How similar studies have gone: While low-dose CT screening itself is proven to reduce lung cancer deaths, trust-centered, multilevel interventions like this are relatively new and have limited prior testing.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Richmond, Jennifer Ann — Wake Forest University Health Sciences
- Study coordinator: Richmond, Jennifer Ann
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.